Response Genetics, Inc. (RGDX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RGDX Hot Sheet
Join SI Premium – FREE
Response Genetics, Inc. (NASDAQ: RGDX) reported Q2 loss of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $5.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
